Latest news
Vectus Biosystems Issues 176,703 Shares Following Executive and Contractor Option Exercises - KalkineKalkine · Wed, 29 Jul 2026 07:00:00 GMTVectus Biosystems Appoints Dr Tara Speranza as CEO and CTO, Raises $791,000 to Accelerate VB0004 Clinical Development - KalkineKalkine · Tue, 28 Jul 2026 07:00:00 GMT